Graft-Versus-Lymphoma Effect in Relapsed Peripheral T-Cell Non-Hodgkin's Lymphomas After Reduced-Intensity Conditioning Followed by Allogeneic Transplantation of Hematopoietic Cells.
- Corradini, P
- Dodero, A
- Zallio, F
- Caracciolo, D
- Casini, M
- Bregni, M
- Narni, Franco
- Patriarca, F
- Boccadoro, M
- Benedetti, F
- Rambaldi, A
- Gianni, Am
- Tarella, C.
Publication date
January 2004
DOI Publisher
editori attuale: -American Society of Clinical Oncology. , 330 JOHN CARLYLE ST, STE 300, ALEXANDRIA, USA, VA, 22314 precedente: -W B Saunders Company:Fulfillment Department, The Curtis Center, Independence Square West:Philadelphia, PA 19106:(800)654-2452, (215)238-7800, EMAIL: wbspcs@harcourt.com, INTERNET: http://elsevierhealth.com, Fax: (215)238-6445 ISSN
0732-183XAbstract
RIC followed by allogeneic stem-cell transplantation is feasible, has a low treatment-related mortality, and seems to be a promising salvage treatment for relapsed PTCL. These findings suggest that the existence of a graft-versus-T-cell lymphoma effec
Add to ORKG